Company Overview
PROCESSA PHARMACEUTICALS, INC.
PCSARevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-14M
2025 FY
Shares Outstanding
1M
2025 FY
EPS
-10.36USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1533743
Exchange
Nasdaq
Location
US